Israeli Biotech Firm Files for $75 Million Nasdaq IPO

Enzymotec, which makes additives, has 14 products and more in the pipeline.

comments Print
Israeli biotech company Enzymotec has filed to float on Nasdaq under the trading symbol ENZY, intending to raise abut $75 million. The extent of its public float and share price at offering remain to be seen.